期刊文献+

MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma 被引量:12

MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma
下载PDF
导出
摘要 MicroRNAs (miRNAs) are endogenous small non-coding RNAs that repress their targets at post transcriptional level.Existing studies have shown that miRNAs are important regulatory genes in hepatocellular carcinoma (HCC),as either tumor suppressors or oncogenes.MiR-122 is normally downregulated in HCC and regarded as a tumor suppressor.Recently miR-122 has been reported to be regulated by CEBPA,which is then involved in a novel pathway to influence proliferation of tumor cells.However it is unknown whether CEBPA is regulated by miRNAs in HCC.In this study,we find that miR182 is upregulated in HCC model rat,and represses CEBPA in both rat and human.This further improves the current CEBPA/miR-122 pathway that controls the proliferation of tumor cells.These results suggest that miR-182 is a potential oncogene in HCC and could be used as a diagnostic marker and drug target of HCC. MicroRNAs (miRNAs) are endogenous small non-coding RNAs that repress their targets at post transcriptional level.Existing studies have shown that miRNAs are important regulatory genes in hepatocellular carcinoma (HCC),as either tumor suppressors or oncogenes.MiR-122 is normally downregulated in HCC and regarded as a tumor suppressor.Recently miR-122 has been reported to be regulated by CEBPA,which is then involved in a novel pathway to influence proliferation of tumor cells.However it is unknown whether CEBPA is regulated by miRNAs in HCC.In this study,we find that miR182 is upregulated in HCC model rat,and represses CEBPA in both rat and human.This further improves the current CEBPA/miR-122 pathway that controls the proliferation of tumor cells.These results suggest that miR-182 is a potential oncogene in HCC and could be used as a diagnostic marker and drug target of HCC.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2014年第1期17-29,共13页 中国癌症研究(英文版)
基金 supported in part by a start-up grant of Kunming University of Science and Technology given to Yun Zheng a major projects of Shanghai Municipal Health Bureau(No.20100222) given to Xiaolin Wang a Youth Fund of Zhongshan Hospital,Fudan University(No.201102) given to Chenggang Wang
关键词 miR-182 CEBPA MIR-122 hepatocellular carcinoma (HCC) ONCOGENE miR-182 Cebpa miR-122 hepatocellular carcinoma (HCC) oncogene
  • 相关文献

参考文献1

二级参考文献32

  • 1Weir HK,Thun MJ,Hankey BF,Ries LA,Howe HL,Wingo PA,Jemal A,Ward E,Anderson RN,Edwards BK.Annual report to the nation on the status of cancer,1975-2000,featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst 2003; 95:1276-1299
  • 2Greenlee RT,Murray T,Bolden S,Wingo PA.Cancer statistics,2000.CA Cancer J Clin 2000; 50:7-33
  • 3August DA,Ottow RT,Sugarbaker PH.Clinical perspective of human colorectal cancer metastasis.Cancer Metastasis Rev 1984; 3:303-324
  • 4Fearon ER,Vogelstein B.A genetic model for colorectal tumorigenesis.Cell 1990; 61:759-767
  • 5Cho KR,Vogelstein B.Genetic alterations in the adenoma--carcinoma sequence.Cancer 1992; 70:1727-1731
  • 6Vogelstein B,Kinzler KW.The multistep nature of cancer.Trends Genet 1993; 9:138-141
  • 7Smith G,Carey FA,Beattie J,Wilkie MJ,Lightfoot TJ,Coxhead J,Garner RC,Steele RJ,Wolf CR.Mutations in APC,Kirsten-ras,and p53--alternative genetic pathways to colorectal cancer.Proc Natl Acad Sci USA 2002; 99:9433-9438
  • 8Ambros V.microRNAs:tiny regulators with great potential.Cell 2001; 107:823-826
  • 9Bartel DP.MicroRNAs:genomics,biogenesis,mechanism,and function.Cell 2004; 116:281-297
  • 10Carrington JC,Ambros V.Role of microRNAs in plant and animal development.Science 2003; 301:336-338

共引文献40

同被引文献46

引证文献12

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部